HomeAI · summaries
Storia in 4 fonti
U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects
The shot made by Gilead Sciences nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.
- ·
huffpost.com
The FDA Approves Powerful HIV Prevention Drug
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
